Consequently, blockade of mTOR signalling via rapamycin treatment has anti-aging and neuroprotective effects, and has been proposed as a potential therapeutic pharmacological compound to restrict neurodegenerative disorders [59] such as AD [60-62]. This evidence concerns the gene MTOR and Alzheimer disease.